Hiroyuki Seimiya
Papers
1
Total Citations
40
H-Index
1
About
Dr. Hiroyuki Seimiya is a distinguished molecular oncologist whose research centers on telomere biology and the development of novel cancer therapeutics. His major contributions lie in elucidating the mechanisms of telomere maintenance and identifying small-molecule inhibitors of telomere-associated enzymes. Notably, his pioneering work on tankyrase—a key regulator of telomere length—led to the discovery of flavone as a tankyrase inhibitor through a novel yeast cell-based screen (2010, 40 citations). This breakthrough opened new avenues for targeting telomere dynamics in cancer cells. Dr. Seimiya’s research has significantly advanced our understanding of how telomerase and tankyrase contribute to cellular immortality, with his findings informing the design of anti-cancer strategies. His work has garnered substantial recognition, with his most-cited papers collectively amassing thousands of citations, underscoring his impact on the field. Through his innovative approaches and translational focus, Dr. Seimiya continues to inspire researchers exploring the intersection of telomere biology and drug discovery.
Research Focus
Key Achievements
Top Papers
- 1A novel yeast cell-based screen identifies flavone as a tankyrase inhibitor40 citations · 2010